Active Low-Carber Forums
Atkins diet and low carb discussion provided free for information only, not as medical advice.
Home Plans Tips Recipes Tools Stories Studies Products
Active Low-Carber Forums
A sugar-free zone


Welcome to the Active Low-Carber Forums.
Support for Atkins diet, Protein Power, Neanderthin (Paleo Diet), CAD/CALP, Dr. Bernstein Diabetes Solution and any other healthy low-carb diet or plan, all are welcome in our lowcarb community. Forget starvation and fad diets -- join the healthy eating crowd! You may register by clicking here, it's free!

Go Back   Active Low-Carber Forums > Main Low-Carb Diets Forums & Support > Low-Carb Studies & Research / Media Watch > LC Research/Media
User Name
Password
FAQ Members Calendar Mark Forums Read Search Gallery My P.L.A.N. Survey


Reply
 
Thread Tools Display Modes
  #1   ^
Old Fri, Aug-02-02, 17:51
doreen T's Avatar
doreen T doreen T is offline
Forum Founder
Posts: 37,199
 
Plan: LC paleo/ancestral
Stats: 241/188/140 Female 165 cm
BF:
Progress: 52%
Location: Eastern ON, Canada
Default Cardiology groups tout safety and benefits of statins

Last Updated: 2002-08-02 13:04:03 -0400 (Reuters Health)

By Alicia Ault

NEW YORK (Reuters Health) - Cholesterol-lowering drugs called statins are one of the most effective weapons in the battle against heart disease and they are safe, according to a consensus statement by the American Heart Association (AHA), the American College of Cardiology (ACC), and the National Heart, Lung and Blood Institute (NHLBI). The consensus statement, which is a reiteration of these organizations' prior positions, will be published in several medical journals in August.

The groups are also jointly issuing new guidelines for health professionals to address concerns about statins that came up after last August's recall of Baycol, a statin that was made and sold by Bayer.

"The principal reason for the AHA, ACC, and NHLBI getting together to make this statement was to counter the growing concern that these drugs are dangerous and have lots of side effects," said Dr. Richard Pasternak, director of preventive cardiology at Massachusetts General Hospital, and an ACC spokesman.

The guidelines "lay out how people should be monitored, and the kinds of groups more likely to have trouble," Pasternak told Reuters Health.

"For the vast majority of people," he said, statins "are risk-free."

Dr. Claude Lenfant, NHLBI director, said, "We hope this joint advisory will give physicians a good appreciation of appropriate usage of statins and how to monitor for side effects."

The Food and Drug Administration (FDA) found that Baycol was associated with several dozen deaths, as well as hundreds of adverse events related to muscle weakness and a more severe condition called rhabdomyolysis, in which the muscle breaks down. The FDA said all statins have muscle weakness listed as a potential side effect, but that there was no indication that any other drug in the class caused severe problems.

The advocacy group Public Citizen disagreed and petitioned the FDA to add a large warning to all statins about the potential for severe muscle weakness and wasting. Nothing has come of the request.

The ACC and the AHA initially said they believed the severe muscle side effects were limited to Baycol.

After a more in-depth review of existing and on-going research and the FDA's adverse reaction database, the two groups, along with the NHLBI, said they still believe statins are safe, and they developed new guidelines to make sure patients are closely monitored for side effects.

The guidelines help identify patients most at risk for muscle soreness and weakness, which includes people who are extremely old, those who have a small body frame and are frail, those who have more than one severe chronic disease (such as kidney disease and heart disease), and those taking other medications that statins might interact with.

With Baycol, people who also took the cholesterol-lowering drug Lopid (gemfibrozil), a member of the fibrate class of drugs, seemed to have a higher rate of fatal muscle breakdown.

Pasternak said that muscle weakness and rhabdomyolysis was much higher with Baycol than with other statins. Only one in 1,000 patients taking statins will have some muscle soreness, but fatal rhabdomyolysis has been detected in less than one in 1 million people, he said.

General aches and pains that occur in the course of normal, daily living should not concern people taking statins, said Pasternak. But, people "should be reporting any serious muscle problems to their physician, as well as any new and unexpected weakness, or the presence of brown urine."

"The bottom line is that when statins are given properly and monitored appropriately, they can do a tremendous amount to reduce cardiac risk," Pasternak said.

The guidelines are published on the ACC, AHA, and NHLBI websites, and will appear in the August 7 issue of the Journal of the American College of Cardiology and the August 20 issue of Circulation.

http://www.reutershealth.com/archiv...802elin017.html
Reply With Quote
Sponsored Links
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
"Doubts raised over drugs for cholesterol" gotbeer LC Research/Media 8 Thu, Apr-01-04 10:51
Full text: A Randomized Trial Comparing a Very Low tamarian LC Research/Media 0 Thu, Jul-10-03 17:21
Against Statins Voyajer Cholesterol, Heart Disease 4 Sun, Oct-20-02 18:22
Current and Potential Drugs for Treatment of Obesity-Endocrine Reviews Voyajer LC Research/Media 0 Mon, Jul-15-02 18:57


All times are GMT -6. The time now is 02:31.


Copyright © 2000-2024 Active Low-Carber Forums @ forum.lowcarber.org
Powered by: vBulletin, Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.